A citation-based method for searching scientific literature

Paolo Severino, Andrea D'Amato, Silvia Prosperi, Bettina Costi, Danilo Angotti, Lucia Ilaria Birtolo, Cristina Chimenti, Carlo Lavalle, Viviana Maestrini, Massimo Mancone, Francesco Fedele. Heart Fail Rev 2021
Times Cited: 5







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
Faiez Zannad, João Pedro Ferreira, Stuart J Pocock, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Martina Brueckmann, Anne Pernille Ofstad, Egon Pfarr, Waheed Jamal,[...]. Lancet 2020
394
60

Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets.
Paolo Severino, Andrea D'Amato, Silvia Prosperi, Francesca Fanisio, Lucia Ilaria Birtolo, Bettina Costi, Lucrezia Netti, Cristina Chimenti, Carlo Lavalle, Viviana Maestrini,[...]. Int J Mol Sci 2021
6
40

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Theresa A McDonagh, Marco Metra, Marianna Adamo, Roy S Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Chioncel,[...]. Eur Heart J 2021
955
40

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
40

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
Christopher P Cannon, Richard Pratley, Samuel Dagogo-Jack, James Mancuso, Susan Huyck, Urszula Masiukiewicz, Bernard Charbonnel, Robert Frederich, Silvina Gallo, Francesco Cosentino,[...]. N Engl J Med 2020
440
40

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado,[...]. Lancet 2019
40

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
40

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.
John J V McMurray, Hertzel C Gerstein, Rury R Holman, Marc A Pfeffer. Lancet Diabetes Endocrinol 2014
211
20

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Francesco Cosentino, Peter J Grant, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen,[...]. Eur Heart J 2020
20

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
Michael R MacDonald, Mark C Petrie, Fumi Varyani, Jan Ostergren, Eric L Michelson, James B Young, Scott D Solomon, Christopher B Granger, Karl Swedberg, Salim Yusuf,[...]. Eur Heart J 2008
397
20


Diabetes and SGLT2-iss inhibitors in patients with heart failure with preserved or mid-range left ventricular ejection fractions.
Andrea Passantino, Caterina Rizzo, Domenico Scrutinio, Alberto Palazzuoli. Heart Fail Rev 2021
2
50

Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond.
Angela Sciacqua, Elena Succurro, Giuseppe Armentaro, Sofia Miceli, Daniele Pastori, Giuseppe Rengo, Giorgio Sesti. Heart Fail Rev 2021
6
20

Prognostic impact of diabetes in chronic and acute heart failure.
Stefano Ghio, Valentina Mercurio, Andrea Attanasio, Gaetano Asile, Carlo Gabriele Tocchetti, Stefania Paolillo. Heart Fail Rev 2021
1
100

Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants.
Francesca Romana Prandi, Isabella Evangelista, Domenico Sergi, Alberto Palazzuoli, Francesco Romeo. Heart Fail Rev 2022
4
25

Impact of diabetes on cardiopulmonary function: the added value of a combined cardiopulmonary and echocardiography stress test.
Nicola Riccardo Pugliese, Alessandra Pieroni, Nicolò De Biase, Valerio Di Fiore, Lorenzo Nesti, Piergiuseppe Agostoni, Frank Lloyd Dini. Heart Fail Rev 2021
4
25

Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients.
Michele Correale, Olga Lamacchia, Michele Ciccarelli, Giuseppe Dattilo, Lucia Tricarico, Natale Daniele Brunetti. Heart Fail Rev 2021
5
20

Use of disease-modifying drugs in diabetic patients with heart failure with reduced ejection fraction.
Daniele Masarone, Roberta Pacileo, Giuseppe Pacileo. Heart Fail Rev 2021
2
50

Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure.
Alessandra Dei Cas, Sadiya S Khan, Javed Butler, Robert J Mentz, Robert O Bonow, Angelo Avogaro, Diethelm Tschoepe, Wolfram Doehner, Stephen J Greene, Michele Senni,[...]. JACC Heart Fail 2015
187
20


Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
Ovidiu Chioncel, Mitja Lainscak, Petar M Seferovic, Stefan D Anker, Maria G Crespo-Leiro, Veli-Pekka Harjola, John Parissis, Cecile Laroche, Massimo Francesco Piepoli, Candida Fonseca,[...]. Eur J Heart Fail 2017
318
20

Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
Jozef Bartunek, Andre Terzic, Beth A Davison, Gerasimos S Filippatos, Slavica Radovanovic, Branko Beleslin, Bela Merkely, Piotr Musialek, Wojciech Wojakowski, Peter Andreka,[...]. Eur Heart J 2017
116
20

Alterations in Titin Properties and Myocardial Fibrosis Correlate With Clinical Phenotypes in Hemodynamic Subgroups of Severe Aortic Stenosis.
Michael Gotzmann, Susanne Grabbe, Dominik Schöne, Marion von Frieling-Salewsky, Cristobal G Dos Remedios, Justus Strauch, Matthias Bechtel, Johannes W Dietrich, Andrea Tannapfel, Andreas Mügge,[...]. JACC Basic Transl Sci 2018
10
20

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, Martina Brueckmann, Michael Böhm, Vijay K Chopra, João Pedro Ferreira, James L Januzzi, Sanjay Kaul, Ileana L Piña,[...]. Circulation 2022
14
20


Impact of increased venous pressure on kidney function and mortality in cardiovascular patients with preserved ejection fraction.
Anastasios Milkas, Konstantinos Tsioufis, Leonidas Koliastasis, Eleftherios Tsiamis, Dimitris Tousoulis, Jozef Bartunek, Marc Vanderheyden. Curr Med Res Opin 2020
1
100

Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.
Marta de Antonio, Josep Lupón, Amparo Galán, Joan Vila, Elisabet Zamora, Agustín Urrutia, Crisanto Díez, Ramon Coll, Salvador Altimir, Antoni Bayes-Genis. Clin Chim Acta 2013
25
20

Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology.
Giuseppe M C Rosano, Brenda Moura, Marco Metra, Michael Böhm, Johann Bauersachs, Tuvia Ben Gal, Stamatis Adamopoulos, Magdy Abdelhamid, Vasiliki Bistola, Jelena Čelutkienė,[...]. Eur J Heart Fail 2021
42
20

Myocardial Strain in the Assessment of Patients With Heart Failure: A Review.
Thomas H Marwick, Sanjiv J Shah, James D Thomas. JAMA Cardiol 2019
44
20

Frailty and risk for heart failure in older adults: the health, aging, and body composition study.
Hassan Khan, Andreas P Kalogeropoulos, Vasiliki V Georgiopoulou, Anne B Newman, Tamara B Harris, Nicolas Rodondi, Douglas C Bauer, Stephen B Kritchevsky, Javed Butler. Am Heart J 2013
106
20

The Cardiorenal Syndrome in Heart Failure.
Maria Rosa Costanzo. Heart Fail Clin 2020
18
20


A novel ultrasound predictor of pulmonary capillary wedge pressure assessed by the combination of left atrial volume and function: A speckle tracking echocardiography study.
Masanori Kawasaki, Ryuhei Tanaka, Koji Ono, Shingo Minatoguchi, Takatomo Watanabe, Makoto Iwama, Takeshi Hirose, Masazumi Arai, Toshiyuki Noda, Sachiro Watanabe,[...]. J Cardiol 2015
12
20

Left ventricular ejection fraction and volumes: it depends on the imaging method.
Peter W Wood, Jonathan B Choy, Navin C Nanda, Harald Becher. Echocardiography 2014
126
20

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.
S Bouchez, F Fedele, G Giannakoulas, F Gustafsson, V-P Harjola, K Karason, M Kivikko, D von Lewinski, F Oliva, Z Papp,[...]. Cardiovasc Drugs Ther 2018
29
20


Trends in prevalence and outcome of heart failure with preserved ejection fraction.
Theophilus E Owan, David O Hodge, Regina M Herges, Steven J Jacobsen, Veronique L Roger, Margaret M Redfield. N Engl J Med 2006
20

Factors Associated With Hospital Readmission of Heart Failure Patients.
Maitha Abdul-Aziz Al-Tamimi, Syed Wasif Gillani, Mohamed Elhassan Abd Alhakam, Kishore Gnana Sam. Front Pharmacol 2021
3
33

Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.
Thomas M Gorter, Dirk J van Veldhuisen, Johann Bauersachs, Barry A Borlaug, Jelena Celutkiene, Andrew J S Coats, Marisa G Crespo-Leiro, Marco Guazzi, Veli-Pekka Harjola, Stephane Heymans,[...]. Eur J Heart Fail 2018
131
20

Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.
Stefan D Anker, Bridget-Anne Kirwan, Dirk J van Veldhuisen, Gerasimos Filippatos, Josep Comin-Colet, Frank Ruschitzka, Thomas F Lüscher, Gregory P Arutyunov, Michael Motro, Claudio Mori,[...]. Eur J Heart Fail 2018
187
20

A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.
Dimitrios Farmakis, Piergiuseppe Agostoni, Loant Baholli, Andrei Bautin, Josep Comin-Colet, Maria G Crespo-Leiro, Francesco Fedele, Jose Manuel García-Pinilla, George Giannakoulas, Francesco Grigioni,[...]. Int J Cardiol 2019
18
20

Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.
Lucas N L Van Aelst, Mattia Arrigo, Rui Placido, Eiichi Akiyama, Nicolas Girerd, Faiez Zannad, Philippe Manivet, Patrick Rossignol, Marc Badoz, Malha Sadoune,[...]. Eur J Heart Fail 2018
77
20

Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure.
Claire Raphael, Cathy Briscoe, Justin Davies, Zachary Ian Whinnett, Charlotte Manisty, Richard Sutton, Jamil Mayet, Darrel P Francis. Heart 2007
250
20


Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart Failure.
Alberto Palazzuoli, Gaetano Ruocco, Paolo Severino, Luigi Gennari, Filippo Pirrotta, Andrea Stefanini, Francesco Tramonte, Mauro Feola, Massimo Mancone, Francesco Fedele. J Clin Med 2021
1
100

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
Thomas M Maddox, James L Januzzi, Larry A Allen, Khadijah Breathett, Javed Butler, Leslie L Davis, Gregg C Fonarow, Nasrien E Ibrahim, JoAnn Lindenfeld, Frederick A Masoudi,[...]. J Am Coll Cardiol 2021
262
20

Left ventricular ejection fraction and heart failure: an indissoluble marriage?
Donato Mele, Marianna Nardozza, Roberto Ferrari. Eur J Heart Fail 2018
31
20

Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review.
Evelien E S van Riet, Arno W Hoes, Kim P Wagenaar, Alexander Limburg, Marcel A J Landman, Frans H Rutten. Eur J Heart Fail 2016
294
20

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC).
Wouter C Meijers, Antoni Bayes-Genis, Alexandre Mebazaa, Johann Bauersachs, John G F Cleland, Andrew J S Coats, James L Januzzi, Alan S Maisel, Kenneth McDonald, Thomas Mueller,[...]. Eur J Heart Fail 2021
9
20

Patterns of adherence to diuretics, dietary sodium and fluid intake recommendations in adults with heart failure.
Barbara Riegel, Solim Lee, Julia Hill, Marguerite Daus, Foster Osei Baah, Joyce W Wald, George J Knafl. Heart Lung 2019
16
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.